Congenica Appoints New CEO to Drive Global Expansion of Clinical Genomics Business

Read More

Congenica’s Chief Financial Officer Named one of the Top 50 Female Leaders in UK Life Science

Read More

Congenica’s Sapientia selected by Hospital Pediátrico de Coimbra for Portugal’s In2Genome Genetic Disease Diagnosis Project

Read More

Beijing 4P Health Research Institute initiates China’s “100K Wellness Pioneer Project” using UniteGen and Sapientia™ integrated platform

Read More

Congenica Finalist in 2017 Biotech and Money Awards

Read More

NIHR BioResource and Congenica Finalists for Bio-IT World 2017 Best Practices Award

Read More

Congenica completes Series B financing round with investments from China-based BGI, Healthlink and Future Planet

Read More

Congenica and Edico Genome Partner to Speed Analysis from ‘DNA to Diagnosis’ for Inherited Diseases

Read More

Congenica raises £8M ($10M) in Series B financing round to drive international expansion of its genome analysis business

Read More

Whole Genome Analysis Leads To Faster Diagnosis And Cost Benefits

Read More

Congenica Expands in North America with Strategic Appointment

Read More

Congenica Appoints New CEO to Drive Global Expansion of Clinical Genomics Business

Read More

Congenica’s Chief Financial Officer Named one of the Top 50 Female Leaders in UK Life Science

Read More

Congenica’s Sapientia selected by Hospital Pediátrico de Coimbra for Portugal’s In2Genome Genetic Disease Diagnosis Project

Read More

Beijing 4P Health Research Institute initiates China’s “100K Wellness Pioneer Project” using UniteGen and Sapientia™ integrated platform

Read More

Congenica Finalist in 2017 Biotech and Money Awards

Read More

NIHR BioResource and Congenica Finalists for Bio-IT World 2017 Best Practices Award

Read More

Congenica completes Series B financing round with investments from China-based BGI, Healthlink and Future Planet

Read More

Congenica and Edico Genome Partner to Speed Analysis from ‘DNA to Diagnosis’ for Inherited Diseases

Read More

Congenica raises £8M ($10M) in Series B financing round to drive international expansion of its genome analysis business

Read More

Whole Genome Analysis Leads To Faster Diagnosis And Cost Benefits

Read More

Congenica Expands in North America with Strategic Appointment

Read More